Old Web
English
Sign In
Acemap
>
authorDetail
>
Melanie Baccus
Melanie Baccus
University of Texas MD Anderson Cancer Center
Medicine
Regimen
Immunology
Phases of clinical research
Myeloid
4
Papers
18
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Phase II Study of Methotrexate (M), Vincristine (O), Pegylated L-Asparaginase (pA), and Dexamethasone (MOpAD) in Patients with Relapsed and/or Refractory Acute Lymphoblastic Leukemia (ALL)
2012
Blood
Tapan Kadia
Jorge E. Cortes
Deborah A. Thomas
Farhad Ravandi
Naveen Pemmaraju
Naval Daver
Alfonso Quintás-Cardama
Melanie Baccus
Rebecca Garris
Elias Jabbour
Hagop M. Kantarjian
Gautam Borthakur
Show All
Source
Cite
Save
Citations (0)
Phase I/II trial of the MEK1/2 inhibitor GSK1120212 (GSK212) in patients (pts) with relapsed/refractory myeloid malignancies: Evidence of activity in pts with RAS mutation.
2011
Journal of Clinical Oncology
G. Borthakur
Leslie Popplewell
Mark Kirschbaum
James M. Foran
Tapan Kadia
Elias Jabbour
Michael Boyiadzis
Amit Verma
Roland B. Walter
Paul Wissel
L. Xu
John W. Bauman
John Zhu
J. Mazumdar
Melanie Baccus
Jeanne Connor
J. E. Cortes
H. Kantarjian
Show All
Source
Cite
Save
Citations (14)
Phase II study of hyper-CVAD followed by nelarabine consolidation in newly diagnosed patients with T cell acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LL).
2010
Journal of Clinical Oncology
C. E. Vigil
H. Kantarjian
Deborah A. Thomas
S. M. OBrien
F. Ravandi Kashani
Charles Koller
Jan Andreas Burger
Rebecca Garris
Melanie Baccus
S. Faderl
Show All
Source
Cite
Save
Citations (1)
GSK1120212, a MEK1/MEK2 Inhibitor, Demonstrates Acceptable Tolerability and Preliminary Activity In a Dose Rising Trial In Subjects with AML and Other Hematologic Malignancies
2010
Blood
Gautam Borthakur
James M. Foran
Tapan Kadia
Elias Jabbour
Paul Wissel
Donna S. Cox
Yanmei Xu
John W. Bauman
Melanie Baccus
Jeanne Connor
Jorge E. Cortes
Hagop M. Kantarjian
Show All
Source
Cite
Save
Citations (3)
1